Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
LMAT
BUYLeMaitre Vascular, Inc. · Healthcare · United States · $2.2B · Avg Vol: $33M/d
COMPANY DESCRIPTION
LeMaitre Vascular, Inc. is a global provider of medical devices for the treatment of peripheral vascular disease, designing, manufacturing, and marketing a broad portfolio of interventional and implantable devices. LeMaitre Vascular benefits from a comprehensive and specialized product portfolio addressing niche areas of peripheral vascular surgery, supported by a direct sales force. Its focus on innovative solutions for a specific disease state creates a strong competitive advantage.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 161.7M | 193.5M | 219.9M | 249.6M | 15.6% | 256.3M | 280.0M | 305.8M | 10.7% |
| EPS | 0.94 | 1.36 | 1.96 | 2.55 | 39.5% | 2.72 | 3.04 | 3.29 | 13.7% |
| Shares | 22.1M | 22.3M | 22.5M | 22.8M | +3.1% | 22.9M | — | — | — |
| Debt | 16.6M | 19.1M | 185.7M | 185.6M | 123.6% | 189.8M | — | — | — |
| Equity | 268.2M | 297.9M | 337.3M | 393.5M | 13.6% | — | — | — | — |
| Op CF | 25.4M | 36.8M | 44.1M | 81.3M | 47.4% | 87.3M | — | — | — |
| Inv CF | -10.4M | -24.7M | -200.1M | -64.9M | — | — | — | — | — |
| Fin CF | -9.2M | -7.1M | 158.1M | -14.5M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of LMAT are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| LMAT | LeMaitre Vascular, Inc.(you) | $2.2B | 76 | BUY |
| XRAY | DENTSPLY SIRONA Inc. | $2.6B | 74 | BUY |
| MMSI | Merit Medical Systems, Inc. | $4.4B | 79 | BUY |
| ICUI | ICU Medical, Inc. | $3.9B | 83 | STRONG BUY |
| ATRC | AtriCure, Inc. | $1.8B | 55 | HOLD |
| TFX | Teleflex Incorporated | $5.8B | 69 | BUY |
| BLFS | BioLife Solutions, Inc. | $1.5B | 56 | HOLD |
| NVST | Envista Holdings Corporation | $4.3B | 90 | STRONG BUY |
| ATR | AptarGroup, Inc. | $8.4B | 74 | BUY |
| STAA | STAAR Surgical Company | $1.2B | 55 | HOLD |
Peer medians: ROE -25.6% · P/E 27.6x · Gross margin 50.5%